Qube Research & Technologies (QRT)’s CONMED CNMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-84,971	Closed	-$3M	–	3536
2026 Q1	$3M	Sell	84,971 -138,383	-62%	-$5.63M	﹤0.01%	1931
2025 Q4	$9.07M	Buy	223,354 +118,516	+113%	+$5.16M	0.01%	1413
2025 Q3	$4.93M	Buy	104,838 +76,386	+268%	+$3.96M	0.01%	1757
2025 Q2	$1.48M	Buy	28,452 +10,233	+56%	+$562K	﹤0.01%	2315
2025 Q1	$1.1M	Sell	18,219 -4,977	-21%	-$321K	﹤0.01%	2214
2024 Q4	$1.59M	Sell	23,196 -95,378	-80%	-$6.65M	﹤0.01%	1974
2024 Q3	$8.53M	Sell	118,574 -7,208	-6%	-$509K	0.01%	1131
2024 Q2	$8.72M	Sell	125,782 -1	-0%	-$73	0.01%	977
2024 Q1	$10.1M	Buy	125,783 +99,300	+375%	+$8.85M	0.02%	841
2023 Q4	$2.9M	Sell	26,483 -39,916	-60%	-$4.13M	0.01%	1342
2023 Q3	$6.7M	Buy	+66,399	New	+$7.63M	0.02%	807
2022 Q4	–	Sell	-15,470	Closed	-$1.24M	–	2535
2022 Q3	$1.24M	Buy	15,470 +10,830	+233%	+$1.02M	0.01%	1119
2022 Q2	$444K	Buy	+4,640	New	+$557K	﹤0.01%	1453
2020 Q1	–	Sell	-6,072	Closed	-$679K	–	1200
2019 Q4	$679K	Buy	+6,072	New	+$647K	0.02%	798

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CNMD Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of CONMED (CNMD) in Q2 2026, closing a stake of 84,971 shares — an estimated $3M sold.

Qube Research & Technologies (QRT) first reported a position in CNMD in Q4 2019 and held it in 14 quarters. The position peaked at $10.1M in Q1 2024. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Qube Research & Technologies (QRT) reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 84,971 CONMED shares in Q2 2026, an estimated $3M.
Qube Research & Technologies (QRT) first reported a position in CONMED in Q4 2019 and held it in 14 quarters.
Qube Research & Technologies (QRT)'s CONMED position peaked at $10.1M in Q1 2024.
247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.